CIK 0001345099 · Large accelerated filer
MESOBLAST LTD
Sign in to watch- Ticker
- MEOBF
- Exchange
- Nasdaq, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- other
- Phone
- 613 9639 6036
- Business address
- LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, Australia, 3000
Securities
- MESO American Depositary Shares Nasdaq
- MEOBF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-09 | George Gregory Director | Purchase | +20,000 | $14.30 | $286K | 13,526,650 |
| 2026-04-09 | George Gregory Director | Purchase | +10,000 | $14.30 | $143K | 13,536,650 |
| 2026-04-09 | George Gregory Director | Purchase | +5,240 | $14.25 | $75K | 13,541,890 |
| 2026-04-09 | George Gregory Director | Purchase | +10,000 | $14.25 | $143K | 13,551,890 |
| 2026-04-09 | George Gregory Director | Purchase | +5,000 | $14.30 | $72K | 13,556,890 |
| 2026-04-09 | George Gregory Director | Purchase | +10,000 | $14.30 | $143K | 13,566,890 |
| 2026-04-09 | George Gregory Director | Purchase | +10,000 | $14.30 | $143K | 13,576,890 |
| 2026-04-09 | George Gregory Director | Purchase | +10,000 | $14.10 | $141K | 13,586,890 |
| 2026-04-04 | George Gregory Director | Purchase | +4,000,000 | $1.42 | $5.7M | 12,000,000 |
| 2026-04-04 | George Gregory Director | Purchase | +4,000,000 | $1.42 | $5.7M | 12,000,000 |
| 2025-12-23 | OBRIEN JAMES MICHAEL Chief Financial Officer | Grant or award · Option (Right to buy) | +650,000 | 650,000 |
Page 2 of 2 · 31 trades